These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 417052)

  • 21. Extended surgical adjuvant thiotepa for mammary carcinoma.
    Donegan WL
    Arch Surg; 1974 Aug; 109(2):187-92. PubMed ID: 4211024
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapy of gynecologic tumors].
    J Gynecol Obstet Biol Reprod (Paris); 1976 Dec; 5(8):1077-90. PubMed ID: 192786
    [No Abstract]   [Full Text] [Related]  

  • 23. [Breast neoplasms. Progress by means of adjuvant chemotherapy?].
    Senn HJ
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):10-5. PubMed ID: 6767909
    [No Abstract]   [Full Text] [Related]  

  • 24. Thio-tepa and endoxan in combined treatment of breast cancer (cooperative trial).
    Blokhina NG; Karev NI
    Radiobiol Radiother (Berl); 1974; 15(3):357-60. PubMed ID: 4217461
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant chemotherapy.
    Cole WH; Mrazek RG; Economou SG; McDonald GO; Slaughter DP; Strehl FW
    Cancer; 1965 Dec; 18(12):1529-35. PubMed ID: 4954364
    [No Abstract]   [Full Text] [Related]  

  • 26. Favorable factors in the adjuvant therapy of breast cancer.
    Carpenter JT; Maddox WA; Laws HL; Wirtschafter DD; Soong SJ
    Cancer; 1982 Jul; 50(1):18-23. PubMed ID: 7044517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy in primary therapy of cancer of the breast.
    Ansfield FJ
    Cancer; 1967 Jul; 20(7):1054-5. PubMed ID: 4961154
    [No Abstract]   [Full Text] [Related]  

  • 28. High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma.
    Kaminer LS; Williams SF; Beschorner J; O'Brien S; Golick J; Bitran JD
    Bone Marrow Transplant; 1989 Jul; 4(4):359-62. PubMed ID: 2505879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy of breast cancer.
    Carter SK
    N Engl J Med; 1981 Jan; 304(1):45-7. PubMed ID: 7001243
    [No Abstract]   [Full Text] [Related]  

  • 30. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
    Fisher B; Glass A; Redmond C; Fisher ER; Barton B; Such E; Carbone P; Economou S; Foster R; Frelick R; Lerner H; Levitt M; Margolese R; MacFarlane J; Plotkin D; Shibata H; Volk H
    Cancer; 1977 Jun; 39(6 Suppl):2883-903. PubMed ID: 194679
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant chemotherapy in breast cancer.
    Musselman MM
    Proc Natl Cancer Conf; 1964; 5():209-14. PubMed ID: 4955151
    [No Abstract]   [Full Text] [Related]  

  • 32. Ten-year survival rates in breast cancer using combination chemotherapy.
    Hancock K; Peet BG; Price JJ; Watson GW; Stone J; Turner RL
    Br J Surg; 1977 Feb; 64(2):134-8. PubMed ID: 407964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials on adjuvant chemotherapy for breast cancer.
    Semiglazov VF; Bavli JL; Moiseyenko VM; Rzhankov SV; Migmanova NS; Popova RT; Seleznyov IK; Kremen BV; Kostetskaya TV; Barash NJ
    Cancer; 1986 May; 57(10):1957-60. PubMed ID: 3082506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
    Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
    J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of adjuvant therapy: results of The National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials.
    Fisher B
    Cancer; 1971 Dec; 28(6):1654-8. PubMed ID: 5001819
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.
    Glass A; Wieand HS; Fisher B; Redmond C; Lerner H; Wolter J; Shibata H; Plotkin D; Foster R; Margolese R; Wolmark N
    Cancer Treat Rep; 1981; 65(5-6):363-76. PubMed ID: 7016322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.